Characterizing genetic architecture of clinical subtypes may accelerate targeted therapy
The relationship between MTHFR variants and thrombosis risk is a complex issue, but current evidence points to no association between the most common variants and an elevated risk
International collaboration is most genetically diverse study of the disease to date
Study suggests sex-specific pathways show potential for sex-specific therapeutic approaches
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
A conversation with Feixiong Cheng, PhD, about his wide-ranging research initiatives
One-time infusion of adenovirus-based therapy is designed to restore heart muscle function
Studying gender-specific health factors promises new insight into diagnosis, prognosis, treatment
Consortium is uncovering risk factors that spur disease development in an understudied group
Authors discuss ethical challenges associated with sponsored genetic testing
Discovery Accelerator Partnership with IBM Deploys Advanced Computing Technologies to Supercharge Healthcare Research